Correction to: Oncogene (2019) 38:1256–1268 https://doi.org/10.1038/s41388-018-0511-x, published online 25 September 2018
After the publication of this article, the authors noted errors in Supplementary Figs. 2 and 6.
In Supplementary Fig. 2, panel E, the same image was mistakenly presented for both miR-221 exo and anti-NC exo.
In Supplementary Fig. 6, panel A, the incorrect image was presented to show anti-221 exo plus SiRNA.
The authors confirm that these errors do not alter the conclusions of the paper.
The corrected figures are given below:
Author information
Authors and Affiliations
Corresponding authors
Additional information
The original article can be found online at https://doi.org/10.1038/s41388-018-0511-x.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhou, CF., Ma, J., Huang, L. et al. Correction to: Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1. Oncogene 41, 1231–1233 (2022). https://doi.org/10.1038/s41388-021-02165-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-021-02165-x
- Springer Nature Limited